Phase 2 clinical trial of VAL-083 as first-line treatment in newly-diagnosed MGMT-unmethylated glioblastoma multiforme (GBM): Halfway report
用户dezZ-X6r0Kf0
12天前
52
10
已关闭
DOI: 10.4103/glioma.glioma_25_19
文献链接: https://journals.lww.com/10.4103/glioma.glioma_25_19
其他信息:
出版社: Medknow
作者: Dennis Brown; Zhong-ping Chen; Chengcheng Guo; Qunying Yang; Jiawei Li; Shaoxiong Wu; Meiling Deng; Xiaojing Du; Ke Sai; Xiaobing Jiang; Zhenghe Chen; Ji Zhang; Fuhua Lin; Jian Wang; Yinsheng Chen; Chao Ke; Xiangheng Zhang; Xue Ju; Yonggao Mou; Jeffrey Bacha; Anne Steino; Sarath Kanekal; Claire Kwan; Gregory Johnson; Richard Schwartz; John Langlands
